Morgan Stanley raised the firm’s price target on Adient (ADNT) to $22 from $20 and keeps an Equal Weight rating on the shares after the company delivered strong quarterly results and raised its 2026 guidance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADNT: